Dendreon Corporation is a biotechnology company whose mission is to target cancer and transform lives through the discovery, development, commercialization, and manufacturing of novel therapeutics. The Company applies its expertise in antigen identification, engineering, and cell processing to produce active cellular immunotherapy (ACI) product candidates designed to stimulate an immune response in a variety of tumor types.

from http://www.dendreon.com/about/

Publications show all

Dendreon has published 40 articles.

Patents show all

211Issued122Applications

Clinical Trials show all

12Phase 24Phase 32N/A2Phase 1

SEC Filings show all

8-K20210-Q4410-K14D1S-11

Contact Information


(877) 256-4545

    Overview

    Total FundingEmployeesLast Funding DateStatus
    1001-5000Acquired